Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaniv Lustig

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 2, 2021
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, IsraelYaniv Lustig, Neta Zuckerman, Ital Nemet, et al.
Vaccine|September 10, 2024
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workersMichal Canetti, Noam Barda, Yaniv Lustig, et al.
Frontiers in Microbiology|February 7, 2024
Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemicIlana S Fratty, Menucha Jurkowicz, Neta Zuckerman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 26, 2021
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody responseYael Peled, Eilon Ram, Jacob Lavee, et al.
European Journal of Cancer (Oxford, England : 1990)|April 19, 2022
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumoursOfer Margalit, Einat Shacham-Shmueli, Amit Itay, et al.
Tropical Medicine and Infectious Disease|September 22, 2022
Can Biomarkers of Oxidative Stress in Serum Predict Disease Severity in West Nile Virus Infection? A Pilot StudyMaxim Van Herreweghe, Annelies Breynaert, Tess De Bruyne, et al.
Vaccines|October 28, 2023
Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter SeasonStephen Moss, Menucha Jurkowicz, Ital Nemet, et al.
Journal of Medical Virology|November 15, 2024
Molecular Analysis of Coxsackievirus B2 Associated With Severe Symptoms of the Central Nervous SystemIlana S Fratty, Or Kriger, Leah Weiss, et al.
Microorganisms|July 29, 2023
Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal StudyGili Joseph, Carmit Cohen, Carmit Rubin, et al.
American Journal of Obstetrics & Gynecology MFM|September 21, 2021
Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancyOmer Nir, Anat Schwartz, Shlomi Toussia-Cohen, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 2, 2021
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, IsraelYaniv Lustig, Neta Zuckerman, Ital Nemet, et al.
Vaccine|September 10, 2024
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workersMichal Canetti, Noam Barda, Yaniv Lustig, et al.
Frontiers in Microbiology|February 7, 2024
Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemicIlana S Fratty, Menucha Jurkowicz, Neta Zuckerman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 26, 2021
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody responseYael Peled, Eilon Ram, Jacob Lavee, et al.
European Journal of Cancer (Oxford, England : 1990)|April 19, 2022
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumoursOfer Margalit, Einat Shacham-Shmueli, Amit Itay, et al.
Tropical Medicine and Infectious Disease|September 22, 2022
Can Biomarkers of Oxidative Stress in Serum Predict Disease Severity in West Nile Virus Infection? A Pilot StudyMaxim Van Herreweghe, Annelies Breynaert, Tess De Bruyne, et al.
Vaccines|October 28, 2023
Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter SeasonStephen Moss, Menucha Jurkowicz, Ital Nemet, et al.
Journal of Medical Virology|November 15, 2024
Molecular Analysis of Coxsackievirus B2 Associated With Severe Symptoms of the Central Nervous SystemIlana S Fratty, Or Kriger, Leah Weiss, et al.
Microorganisms|July 29, 2023
Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal StudyGili Joseph, Carmit Cohen, Carmit Rubin, et al.
American Journal of Obstetrics & Gynecology MFM|September 21, 2021
Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancyOmer Nir, Anat Schwartz, Shlomi Toussia-Cohen, et al.
Pageof 15